Therapeutic potential of natural products in ischemic stroke: targeting angiogenesis
Ischemic stroke (IS), a leading global cause of mortality and long-term disability, necessitates immediate intervention for eligible patients. Current guidelines mandate intravenous thrombolysis within 4.5 h of symptom onset for individuals without contraindications, achieving vessel recanalization...
Saved in:
| Main Authors: | WenQiang Li, E. Liu, YiHao Zhou, ZhiChao Liao, DongYan Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1579172/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bidirectional Role of Pericytes in Ischemic Stroke
by: Jingya Xu, et al.
Published: (2025-06-01) -
Research Progress on the Mechanism of Acupuncture Treatment of Ischemic Stroke Based on the Space Construction of Nerve-vascular Unit
by: LI Mengxing, et al.
Published: (2022-02-01) -
Targeting the neurovascular unit: Therapeutic potential of traditional Chinese medicine for the treatment of stroke
by: Bingxin Wu, et al.
Published: (2024-10-01) -
Reinforcement of Transdural Angiogenesis: A Novel Approach to Treating Ischemic Stroke With Cerebral Perfusion Impairment
by: Ji Man Hong, et al.
Published: (2025-01-01) -
Editorial: From bench to bedside: inflammation in neurovascular disorders and stroke
by: Mohd Farooq Shaikh, et al.
Published: (2025-07-01)